A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria

Fansimef is a combination of 250 mg mefloquine (base), 500 mg sulfadoxine, and 25 mg pyrimethamine per tablet. One hundred and fifty adult male Brazilian patients at Belém (Pará), who had peripheral blood smears positive for Plasmodium falciparum, with or without clinical symptoms of falciparum mala...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: de Souza, J. M., Sheth, U. K., Wernsdorfer, W. H., Trigg, P. I., Doberstyn, E. B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1987
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2490994/
https://ncbi.nlm.nih.gov/pubmed/3311438
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller